La última vez que Britney Spears compareció ante un juez, en junio, se enfureció cuando contó como la obligaron a recibir atención psiquiátrica que le costaba $60,000 al mes. Aunque las circunstancias de la estrella pop y su tutela financiera son inusuales, cada año cientos de miles de otros pacientes psiquiátricos también reciben atención contra

The approval of a controversial new drug for Alzheimer’s disease, Aduhelm, is shining a spotlight on mild cognitive impairment — problems with memory, attention, language or other cognitive tasks that exceed changes expected with normal aging. After initially indicating that Aduhelm could be prescribed to anyone with dementia, the Food and Drug Administration now specifies

When Britney Spears last went before a judge, in June, she bristled as she told of being forced into psychiatric care that cost her $60,000 a month. Though the pop star’s circumstances in a financial conservatorship are unusual, every year hundreds of thousands of other psychiatric patients also receive involuntary care, and many are stuck